OnCo

MYO5A (Unconventional myosin-Va) is a gene that drives cell growth when it is altered. The public catalogues list it as an oncogene driver and a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Breast cancer, Hepatocellular carcinoma, Lung cancer and 1 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

Processive actin-based motor that can move in large steps approximating the 36-nm pseudo-repeat of the actin filament. Can hydrolyse ATP in the presence of actin, which is essential for its function as a motor protein. Involved in melanosome transport. Also mediates the transport of vesicles to the plasma membrane. May also be required for some polarisation process involved in dendrite formation. Locus 15q21.2 (HGNC).

Where it is found
  • Breast cancer: IntOGen driver in 1 cohort (BRCA)
  • Hepatocellular carcinoma: IntOGen driver in 1 cohort (HCC)
  • Lung cancer: IntOGen driver in 1 cohort (LUNG)
  • Neuroblastoma: IntOGen driver in 1 cohort (NBL)
Class: oncogene · Gene: MYO5A · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"MYO5A" OR ABSTRACT:"MYO5A" OR TITLE:"myosin VA" OR ABSTRACT:"myosin VA" OR TITLE:"Unconventional myosin-Va" OR ABSTRACT:"Unconventional myosin-Va" OR TITLE:"MYO5" OR ABSTRACT:"MYO5" OR TITLE:"GS1" OR ABSTRACT:"GS1" OR TITLE:"MYR12" OR ABSTRACT:"MYR12") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about MYO5A, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/myo5a.json. Licence CC BY-NC 4.0.